PathogenDx
Scottsdale, US · Founded 2015 · Delaware corporation · 3 known investors
Find your way into PathogenDx
175 people in our graph share verified history with the PathogenDx team — schools, employers, funds. One of them is your warm intro.
Glen Andersonunlockedknows Milan Patel · together at University of Michigan (overlapped)
×10knows the team · via Intel Corporation
knows the team · via University of Michigan
PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
Founders & leadership
PathogenDx was founded in 2015 by Michael Hogan and Milan Patel.
MH
Michael HoganCSO
MP
Milan PatelinCEO and Co-FounderMilan Patel has over twenty years of experience in corporate and entrepreneurial settings, ranging from small and mid-size businesses to Fortune 50 companies. He is CEO of PathogenDx, which provides molecular pathogen detection assays for rapid identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
EL
Eric LachanceinCo-Founder and Board Member
Investors · 3
Reported raises · per SEC filings
Form D private placements$675K disclosed across 1 round · 2016
▶$675KraisedApr 2016 · 4 investors · Biotechnology
▶$675KraisedApr 2016 · 4 investors · Biotechnology
Officers, directors & promoters on the filing
- Eric LachanceExecutive Officer, Director
- Michael HoganExecutive Officer, Director
- Milan PatelExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $675K
- Minimum investment
- $50K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapGendx20 shared keywordsGenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.
Genedx15 shared keywordsGeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.
CareDx14 shared keywordsCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
Medicinalgenomics14 shared keywordsMedicinal Genomics provides microbial and plant testing solutions for the cannabis, nutraceutical, and food safety industries through validated qPCR assays and automated liquid handling platforms. Their offerings enable rapid pathogen detection and species identification with turnaround times measured in hours rather than days.
Companies competing with PathogenDx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does PathogenDx do?
- PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
- Who founded PathogenDx?
- PathogenDx was founded by Michael Hogan, Milan Patel in 2015.
- Who are PathogenDx's investors?
- PathogenDx's investors include 7thirty, Altitude Investment Management, Salveo Capital.
- How much funding has PathogenDx raised?
- PathogenDx has disclosed $675K raised across 1 round.
- Where is PathogenDx headquartered?
- PathogenDx is headquartered in Scottsdale, US.